Variant report
Variant | esv3445389 |
---|---|
Chromosome Location | chr11:55761132-55782594 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr11:55768300-55768450 | HFF-Myc | foreskin: | n/a | n/a |
2 | CTCF | chr11:55764276-55764363 | Lung_OC | lung: | n/a | n/a |
3 | CTCF | chr11:55768480-55768630 | HFF-Myc | foreskin: | n/a | n/a |
4 | CTCF | chr11:55771900-55772050 | GM06990 | blood: | n/a | n/a |
5 | CUX1 | chr11:55781307-55781462 | GM12878 | blood: | n/a | n/a |
6 | E2F4 | chr11:55780435-55780593 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | EBF1 | chr11:55771813-55772216 | GM12878 | blood: | n/a | n/a |
8 | EBF1 | chr11:55781369-55781629 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr11:55781306-55781795 | GM12878 | blood: | n/a | n/a |
10 | EP300 | chr11:55781302-55781784 | GM12878 | blood: | n/a | n/a |
11 | JUN | chr11:55764558-55764677 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | MXI1 | chr11:55781337-55781444 | GM12878 | blood: | n/a | n/a |
13 | POLR2A | chr11:55771762-55771912 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr11:55776149-55776172 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr11:55761998-55762134 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr11:55771433-55771508 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | POLR2A | chr11:55780115-55780150 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr11:55770539-55770552 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | STAT1 | chr11:55772221-55772381 | GM12878 | blood: | n/a | n/a |
20 | STAT3 | chr11:55764378-55764578 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5F1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149961467 | chr11:55761208-55761209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371025064 | chr11:55761218-55761219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2449134 | chr11:55761221-55761222 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs571978450 | chr11:55761230-55761231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs66470326 | chr11:55761251-55761252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77110658 | chr11:55761256-55761257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201874701 | chr11:55761259-55761260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11825964 | chr11:55761270-55761271 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs148858000 | chr11:55761276-55761277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs80272096 | chr11:55761281-55761282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375364958 | chr11:55761282-55761283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368044547 | chr11:55761292-55761293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115038777 | chr11:55761298-55761299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141507953 | chr11:55761310-55761311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200882120 | chr11:55761332-55761333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs58625186 | chr11:55761338-55761339 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs370696479 | chr11:55761352-55761353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371962080 | chr11:55761355-55761356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs377087548 | chr11:55761365-55761366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540902518 | chr11:55761382-55761383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs267602986 | chr11:55761386-55761387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561974760 | chr11:55761392-55761393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138514211 | chr11:55761408-55761409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369455612 | chr11:55761410-55761411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144082157 | chr11:55761412-55761413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs367584917 | chr11:55761434-55761435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530485082 | chr11:55761441-55761442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147257465 | chr11:55761442-55761443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373538766 | chr11:55761455-55761456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139679637 | chr11:55761463-55761464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376723028 | chr11:55761468-55761469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201345840 | chr11:55761479-55761480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373022460 | chr11:55761489-55761490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149807324 | chr11:55761493-55761494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs376057556 | chr11:55761508-55761509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs35607186 | chr11:55761528-55761529 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs148461158 | chr11:55761566-55761567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs202190872 | chr11:55761567-55761568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144072291 | chr11:55761579-55761580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370503254 | chr11:55761585-55761586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146483599 | chr11:55761593-55761594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145426776 | chr11:55761605-55761606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372684113 | chr11:55761654-55761655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143461910 | chr11:55761661-55761662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs201523946 | chr11:55761685-55761686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376239660 | chr11:55761690-55761691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374750748 | chr11:55761698-55761699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368793724 | chr11:55761715-55761716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190524347 | chr11:55761719-55761720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146676493 | chr11:55761727-55761728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 17142309 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:55761200-55761400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr11:55761400-55762600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr11:55762600-55763600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr11:55762800-55764200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |